Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Allergan
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Female participants willing to minimize the risk of inducing pregnancy for the duration of the clinical study and follow-up period
A female participant is eligible to participate if she is not pregnant (has a negative urine pregnancy result prior to randomization), not breastfeeding, and at least one of the following conditions applies:
1. Not a woman of childbearing potential (WOCBP) OR
2. A WOCBP who agrees to follow the studies contraceptive guidance during the treatment and follow-up period through study exit.
Capable of giving signed informed consent, which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in this study's protocol
You may not be if
Any medical condition that may put the participant at increased medical risk with exposure to BOTOX®, including diagnosed myasthenia gravis, Eaton-Lambert syndrome, amyotrophic lateral sclerosis, or any other condition that might interfere with neuromuscular function
Participant has an anticipated need for treatment with botulinum toxin of any serotype for any indication during the study (other than study intervention)
Anticipated need for surgery or overnight hospitalization during the study
Current enrollment in an investigational drug or device study or participation in such a study within 30 days of entry into this study
Females who are pregnant, nursing, or planning a pregnancy during the study
Known immunization or hypersensitivity to any botulinum toxin serotype
History of alcohol or drug abuse within 12 months of the study
Participant has tattoos, jewelry, or clothing that cannot be removed, and that obscure the neck
Clareo Health | BOTOX® for the Treatment of Platysma Prominence
